IL-2 coordinates IL-2-producing and regulatory T cell interplay

Journal of Experimental Medicine

Volumn 210, Issue 12, 2013, Pages 2707-2720

  Amado, Inês F ^a,b,c   Berges, Julien ^a,b,d   Luther, Rita J ^e,f   Mailhé, Marie Pierre ^a,b   Garcia, Sylvie ^a,b   Bandeira, Antonio ^a,b   Weaver, Casey ^e,f   Liston, Adrian ^g   Freitas, Antonio A ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c UNIVERSITY OF PORTO   (Portugal)

^d SORBONNE UNIVERSITÉ   (France)

^e University of Alabama at Birmingham   (United States)

^f University of Alabama at Birmingham   (United States)

^g UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEEDBACK SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; REGULATORY T LYMPHOCYTE;

ANIMALS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SELF TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84888092265     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122759     Document Type: Article

References (55)

1. Almeida, A.R., N. Legrand, M. Papiernik, and A.A. Freitas. 2002. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169:4850-4860.
2. Almeida, A.R., B. Zaragoza, and A.A. Freitas. 2006. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J. Immunol. 177:192-200.
3. Almeida, A.R.M., I.F. Amado, J. Reynolds, J. Berges, G. Lythe, C. Molina-Paris, and A.A. Freitas. 2012. Quorum sensing in CD4+ T cell homeostasis:a hypothesis and a model. Front Immunol. 3:1-15. http://dx.doi .org/10.3389/fimmu.2012.00125
4. Barthlott, T., G. Kassiotis, and B. Stockinger. 2003. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197:451-460.
5. Bayer, A.L., A. Yu, D. Adeegbe, and T.R. Malek. 2005. Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period. J. Exp. Med. 201:769-777. http://dx.doi.org/10.1084/jem.20041179
6. Boyman, O., M. Kovar, M.P. Rubinstein, C.D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science. 311:1924-1927. http://dx.doi.org/10.1126/science.1122927
7. Burchill, M.A., J. Yang, C. Vogtenhuber, B.R. Blazar, and M.A. Farrar. 2007. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178:280-290.
8. de Freitas, A.A. 2009. Tractus immuno-logicus: a brief history of the immune system. Landes Bioscience, Austin, Texas.
9. Dinh, T.N., T.S. Kyaw, P. Kanellakis, K. To, P. Tipping, B.H. Toh, A. Bobik, and A. Agrotis. 2012. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Circulation. 126:1256-1266. http://dx.doi.org/10.1161/CIRCULATIONAHA.112.099044
10. Fehérvari, Z., T. Yamaguchi, and S. Sakaguchi. 2006. The dichotomous role of IL-2: tolerance versus immunity. Trends Immunol. 27:109-111. http://dx.doi.org/10.1016/j.it.2006.01.005
11. Ferran, C., M. Dy, K. Sheehan, S. Merite, R. Schreiber, P. Landais, G. Grau, J. Bluestone, J.F. Bach, and L. Chatenoud. 1991. Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release. Clin. Exp. Immunol. 86:537-543. http://dx.doi.org/10.1111/j.1365-2249.1991 .tb02966.x
12. Fontenot, J.D., J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky. 2005a. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6:1142-1151. http://dx.doi.org/10.1038/ni1263
13. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005b. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341. http://dx.doi.org/10.1016/j.immuni.2005.01.016
14. Freitas, A.A., and B. Rocha. 2000. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18:83-111. http://dx.doi.org/10.1146/annurev.immunol.18.1.83
15. Gavin, M.A., S.R. Clarke, E. Negrou, A. Gallegos, and A. Rudensky. 2002. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3:33-41. http://dx.doi.org/10.1038/ni743
16. Gregersen, P.K., and L.M. Olsson. 2009. Recent advances in the genetics of autoimmune disease. Annu. Rev. Immunol. 27:363-391. http://dx.doi .org/10.1146/annurev.immunol.021908.132653
17. Grinberg-Bleyer, Y., A. Baeyens, S. You, R. Elhage, G. Fourcade, S. Gregoire, N. Cagnard, W. Carpentier, Q. Tang, J. Bluestone, et al. 2010. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 207:1871-1878. http://dx.doi.org/10.1084/jem.20100209
18. Hill, J.A., M. Feuerer, K. Tash, S. Haxhinasto, J. Perez, R. Melamed, D. Mathis, and C. Benoist. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. 27:786-800. http://dx.doi.org/10.1016/j.immuni.2007.09.010
19. Huang, C.T., C.J. Workman, D. Flies, X. Pan, A.L. Marson, G. Zhou, E.L. Hipkiss, S. Ravi, J. Kowalski, H.I. Levitsky, et al. 2004. Role of LAG-3 in regulatory T cells. Immunity. 21:503-513. http://dx.doi.org/10.1016/j.immuni.2004.08.010
20. Josefowicz, S.Z., L.F. Lu, and A.Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30:531-564.
21. Kim, J.M., J.P. Rasmussen, and A.Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8:191-197. http://dx.doi.org/10.1038/ni1428
22. Long, M., and A.J. Adler. 2006. Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response. J. Immunol. 177:4257-4261.
23. Luther, R.J. 2009. Development and implementation of knock-in and BAC-in IL-2 reporter mouse models to characterize Il2 gene regulation in CD4 T cells. In The University of Alabama at Birmingham, Birmingham. p159.
24. Malek, T.R. 2008. The biology of interleukin-2. Annu. Rev. Immunol. 26:453-479. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090357
25. Malek, T.R., and I. Castro. 2010. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity. 33:153-165. http://dx.doi.org/10.1016/j.immuni.2010.08.004
26. Malek, T.R., B.O. Porter, E.K. Codias, P. Scibelli, and A. Yu. 2000. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164:2905-2914.
27. McCaughtry, T.M., M.S. Wilken, and K.A. Hogquist. 2007. Thymic emigration revisited. J. Exp. Med. 204:2513-2520. http://dx.doi.org/10 .1084/jem.20070601
28. Naramura, M., R.J. Hu, and H. Gu. 1998. Mice with a fluorescent marker for interleukin 2 gene activation. Immunity. 9:209-216. http://dx.doi .org/10.1016/S1074-7613(00)80603-2
29. Onishi, Y., Z. Fehervari, T. Yamaguchi, and S. Sakaguchi. 2008. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA. 105:10113-10118. http://dx.doi.org/10.1073/pnas.0711106105
30. Ono, M., H. Yaguchi, N. Ohkura, I. Kitabayashi, Y. Nagamura, T. Nomura, Y.Miyachi, T. Tsukada, and S. Sakaguchi. 2007. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature. 446:685-689. http://dx.doi.org/10.1038/nature05673
31. Qureshi, O.S., Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti, E.M. Schmidt, J. Baker, L.E. Jeffery, S. Kaur, Z. Briggs, et al. 2011. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 332:600-603. http://dx.doi.org/10.1126/science .1202947
32. Rudensky, A.Y. 2011. Regulatory T cells and Foxp3. Immunol. Rev. 241:260-268. http://dx.doi.org/10.1111/j.1600-065X.2011.01018.x
33. Saadoun, D., M. Rosenzwajg, F. Joly, A. Six, F. Carrat, V. Thibault, D.Sene, P. Cacoub, and D. Klatzmann. 2011. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 365:2067-2077. http://dx.doi.org/10.1056/NEJMoa1105143
34. Sadlack, B., J. Löhler, H. Schorle, G. Klebb, H. Haber, E. Sickel, R.J. Noelle, and I. Horak. 1995. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25:3053-3059. http://dx.doi.org/10.1002/eji.1830251111
35. Schorle, H., T. Holtschke, T. Hünig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 352:621-624. http://dx.doi.org/10.1038/352621a0
36. Setoguchi, R., S. Hori, T. Takahashi, and S. Sakaguchi. 2005. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201:723-735. http://dx.doi.org/10.1084/jem.20041982
37. Shevach, E.M. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423-449. http://dx.doi.org/10.1146/annurev.immunol.18.1.423
38. Snow, J.W., N. Abraham, M.C. Ma, B.G. Herndier, A.W. Pastuszak, and M.A.Goldsmith. 2003. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171:5042-5050.
39. Sojka, D.K., D. Bruniquel, R.H. Schwartz, and N.J. Singh. 2004. IL-2 secretion by CD4+ T cells in vivo is rapid, transient, and influenced by TCR-specific competition. J. Immunol. 172:6136-6143.
40. Soper, D.M., D.J. Kasprowicz, and S.F. Ziegler. 2007. IL-2Rbeta links IL-2R signaling with Foxp3 expression. Eur. J. Immunol. 37:1817-1826. http://dx.doi.org/10.1002/eji.200737101
41. Suzuki, H., T.M. Kündig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J.J. Simard, P.S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 268:1472-1476. http://dx.doi.org/10.1126/science.7770771
42. Thornton, A.M., and E.M. Shevach. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296. http://dx.doi.org/10.1084/jem.188.2.287
43. Todd, J.A. 2010. Etiology of type 1 diabetes. Immunity. 32:457-467. http://dx.doi.org/10.1016/j.immuni.2010.04.001
44. Vaeth, M., T. Gogishvili, T. Bopp, M. Klein, F. Berberich-Siebelt, S. Gattenloehner, A. Avots, T. Sparwasser, N. Grebe, E. Schmitt, et al. 2011. Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proc. Natl. Acad. Sci. USA. 108:2480-2485. http://dx.doi.org/10.1073/pnas.1009463108
45. Villarino, A.V., C.M. Tato, J.S. Stumhofer, Z. Yao, Y.K. Cui, L. Hennighausen, J.J. O'Shea, and C.A. Hunter. 2007. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J. Exp. Med. 204:65-71. http://dx.doi.org/10.1084/jem.20061198
46. Wan, Y.Y., and R.A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA. 102:5126-5131. http://dx.doi.org/10.1073/pnas.0501701102
47. Willerford, D.M., J. Chen, J.A. Ferry, L. Davidson, A. Ma, and F.W. Alt. 1995. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3:521-530. http://dx.doi.org/10.1016/1074-7613(95)90180-9
48. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 322:271-275. http://dx.doi .org/10.1126/science.1160062
49. Wolf, M., A. Schimpl, and T. Hünig. 2001. Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells:evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31:1637-1645. http://dx.doi.org/10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T
50. Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer, A.D. Lapan, J.C. Stroud, D.L. Bates, L. Guo, A. Han, S.F. Ziegler, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 126:375-387. http://dx.doi.org/10.1016/j.cell.2006.05.042
51. Yamanouchi, J., D. Rainbow, P. Serra, S. Howlett, K. Hunter, V.E. Garner, A. Gonzalez-Munoz, J. Clark, R. Veijola, R. Cubbon, et al. 2007. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39:329-337. http://dx.doi.org/10.1038/ng1958
52. Yao, Z., Y. Kanno, M. Kerenyi, G. Stephens, L. Durant, W.T. Watford, A. Laurence, G.W. Robinson, E.M. Shevach, R. Moriggl, et al. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood. 109:4368-4375. http://dx.doi.org/10.1182/blood-2006-11-055756
53. Yu, A., L. Zhu, N.H. Altman, and T.R. Malek. 2009. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity. 30:204-217. http://dx.doi.org/10.1016/j.immuni .2008.11.014
54. Yui, M.A., G. Hernández-Hoyos, and E.V. Rothenberg. 2001. A new regulatory region of the IL-2 locus that confers position-independent transgene expression. J. Immunol. 166:1730-1739.
55. Zaragoza, B., C. Evaristo, A. Kissenpfennig, V. Libri, B. Malissen, B. Rocha, A.A. Freitas, and A.R. Almeida. 2011. Cell-to-cell interactions and signals involved in the reconstitution of peripheral CD8 T(CM) and T(EM) cell pools. PLoS ONE. 6:e17423. http://dx.doi.org/10.1371/journal.pone.0017423